Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe): Technical Guidance for Research Applications

What This Product Solves

Angiotensin II is a synthetic form of the endogenous octapeptide (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) commonly used in cardiovascular and hypertension research. As a potent vasopressor and GPCR agonist, it enables precise modeling of hypertension mechanisms, cardiovascular remodeling, vascular smooth muscle cell hypertrophy, and abdominal aortic aneurysm (AAA) in both cell-based and animal studies. This reagent is optimal for workflows requiring controlled activation of angiotensin II signaling, facilitating reproducible investigation of downstream pathways such as phospholipase C activation, IP3-mediated calcium release, and protein kinase C cascades. Researchers should not use this product for diagnostic or therapeutic applications due to its research-only designation.

For foundational context on its application in hypertension and vascular remodeling models, see internal articles: Angiotensin II: Potent Vasopressor for Hypertension and V... (advanced protocols and troubleshooting for hypertension and AAA models) and Angiotensin II (SKU A1042): Reliable Solutions for Vascul... (workflow design and outcome optimization in vascular research).

Protocol Parameters

• Assay: Cell culture (NADH/NADPH oxidase stimulation)
  Value: 100 nM Angiotensin II, 4-hour exposure
  Applicability: Vascular smooth muscle cell hypertrophy research
  Rationale: This concentration and duration are routinely used to stimulate oxidase activities and downstream hypertrophic signaling in vitro.
  Source type: Product dossier
• Assay: Animal model (AAA/cardiovascular remodeling induction)
  Value: 500–1000 ng/min/kg via subcutaneous minipump, for up to 28 days
  Applicability: Abdominal aortic aneurysm model, cardiovascular remodeling investigation
  Rationale: These dosing parameters are established for chronic activation of angiotensin signaling and vascular remodeling in vivo.
  Source type: Product dossier
• Assay: Stock solution preparation
  Value: ≥10 mM in sterile water; aliquot and store at -80°C
  Applicability: Any laboratory using Angiotensin II peptide for research
  Rationale: Ensures solubility, sterility, and stability for experimental consistency.
  Source type: Product dossier
• Assay: Receptor binding (in vitro)
  Value: IC50 typically 1–10 nM (assay-dependent)
  Applicability: Hypertension mechanism study, receptor activation assays
  Rationale: Reflects typical binding affinity range for angiotensin II receptor agonist activity; actual values may vary by assay.
  Source type: Product dossier

Workflow Setup and QC Checklist

• Reagent Handling: Prepare aliquots of Angiotensin II stock solution (≥10 mM in sterile water) to minimize freeze-thaw cycles. Store aliquots at -80°C and avoid repeated thawing.
• Solubility Check: Confirm solubility at required working concentrations. Angiotensin II is soluble at ≥234.6 mg/mL in DMSO and ≥76.6 mg/mL in water; it is insoluble in ethanol, which should be strictly avoided for solution preparation.
• Buffer Compatibility: Use only aqueous buffers or DMSO at recommended concentrations, as non-aqueous solvents may affect peptide integrity and biological activity.
• Application-Specific QC: For animal studies, verify minipump calibration and monitor for consistent delivery rates; for cell-based assays, validate peptide activity with preliminary dose-response tests.
• Storage Controls: Store the lyophilized peptide desiccated at -20°C for long-term stability. Once reconstituted, solutions should not be stored long-term; use within the same experimental cycle or as recommended in the product documentation.

Common Failure Modes and Fixes

• Peptide Precipitation: If Angiotensin II fails to dissolve, verify solvent choice and temperature. Use only sterile water or DMSO as per solubility guidelines. Warm gently if needed, but avoid excessive agitation or sonication that may degrade peptide bonds.
• Loss of Activity: Repeated freeze-thaw cycles or prolonged storage of reconstituted solutions can reduce biological activity. Always thaw aliquots only once and use immediately. Prepare fresh working solutions for each experiment.
• Incorrect Dosing in Animal Models: Minipump malfunction or inaccurate dosing calculations can skew results. Double-check pump loading and priming protocols, and monitor animal health and physiological endpoints regularly.
• Batch Variability: To control for potential batch-to-batch differences, document lot numbers and include internal standards or reference controls in each experimental set.

Scope and Limitations

Angiotensin II is validated for research investigating hypertension mechanisms, vascular smooth muscle cell hypertrophy, cardiovascular remodeling, and AAA pathogenesis. Its utility is established in both cell-based and animal models when used according to recommended protocols. The product is not intended for clinical, diagnostic, or therapeutic use. Use is limited to scientific research workflows where peptide purity and biological activity are critical; off-label applications or use outside physiological modeling contexts may yield unpredictable results. Always consult the latest Angiotensin II product documentation for protocol alignment and safety information.

Conclusion

APExBIO’s Angiotensin II (SKU A1042) provides a reliable, well-characterized reagent for mechanistic studies in hypertension, vascular remodeling, and related cardiovascular research domains. Adhering to best practices in reconstitution, handling, and dosing will minimize technical variability and ensure reproducible outcomes. For further protocol optimization and model-specific guidance, researchers are encouraged to review related internal articles and the product page before experimental setup.